A detailed history of Two Sigma Investments, LP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 1,204 shares of BIO stock, worth $409,998. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,204
Previous 7,485 83.91%
Holding current value
$409,998
Previous $2.04 Million 80.33%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$263.97 - $344.64 $1.66 Million - $2.16 Million
-6,281 Reduced 83.91%
1,204 $402,000
Q2 2024

Aug 14, 2024

SELL
$268.26 - $339.48 $6.59 Million - $8.35 Million
-24,582 Reduced 76.66%
7,485 $2.04 Million
Q1 2024

May 15, 2024

SELL
$304.11 - $351.99 $287,688 - $332,982
-946 Reduced 2.87%
32,067 $11.1 Million
Q4 2023

Feb 14, 2024

SELL
$269.37 - $365.04 $445,807 - $604,141
-1,655 Reduced 4.77%
33,013 $10.7 Million
Q3 2023

Nov 14, 2023

SELL
$350.25 - $422.63 $8.86 Million - $10.7 Million
-25,307 Reduced 42.2%
34,668 $12.4 Million
Q2 2023

Aug 14, 2023

BUY
$359.49 - $486.4 $17.4 Million - $23.6 Million
48,532 Added 424.12%
59,975 $22.7 Million
Q1 2023

May 15, 2023

SELL
$418.69 - $503.0 $6 Million - $7.21 Million
-14,329 Reduced 55.6%
11,443 $5.48 Million
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $813,856 - $1.06 Million
-2,314 Reduced 8.24%
25,772 $10.8 Million
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $3.01 Million - $4.12 Million
7,306 Added 35.16%
28,086 $11.7 Million
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $24.1 Million - $31.1 Million
-52,057 Reduced 71.47%
20,780 $10.3 Million
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $15.2 Million - $21.4 Million
29,055 Added 66.36%
72,837 $41 Million
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $11.2 Million - $12.5 Million
15,778 Added 56.34%
43,782 $33.1 Million
Q3 2021

Nov 15, 2021

BUY
$657.71 - $825.77 $692,568 - $869,535
1,053 Added 3.91%
28,004 $20.9 Million
Q2 2021

Aug 16, 2021

BUY
$576.64 - $649.04 $627,960 - $706,804
1,089 Added 4.21%
26,951 $17.4 Million
Q1 2021

May 17, 2021

BUY
$547.01 - $662.35 $14.1 Million - $17.1 Million
25,862 New
25,862 $14.8 Million
Q3 2020

Nov 16, 2020

SELL
$454.43 - $535.6 $4.18 Million - $4.93 Million
-9,204 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$334.87 - $493.06 $889,079 - $1.31 Million
-2,655 Reduced 22.39%
9,204 $4.16 Million
Q1 2020

May 15, 2020

SELL
$320.01 - $409.07 $28.2 Million - $36.1 Million
-88,240 Reduced 88.15%
11,859 $4.16 Million
Q4 2019

Feb 14, 2020

SELL
$319.73 - $374.2 $19.5 Million - $22.9 Million
-61,127 Reduced 37.91%
100,099 $37 Million
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $19.9 Million - $22.5 Million
65,224 Added 67.94%
161,226 $53.6 Million
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $3.57 Million - $3.89 Million
-12,446 Reduced 11.48%
96,002 $30 Million
Q1 2019

May 15, 2019

SELL
$224.3 - $317.41 $789,087 - $1.12 Million
-3,518 Reduced 3.14%
108,448 $33.2 Million
Q4 2018

Feb 14, 2019

BUY
$220.1 - $309.0 $8.43 Million - $11.8 Million
38,287 Added 51.96%
111,966 $26 Million
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $254,566 - $287,012
880 Added 1.21%
73,679 $23.1 Million
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $6.39 Million - $7.95 Million
26,159 Added 56.09%
72,799 $21 Million
Q1 2018

May 15, 2018

SELL
$233.97 - $274.11 $8.96 Million - $10.5 Million
-38,275 Reduced 45.07%
46,640 $11.7 Million
Q4 2017

Feb 14, 2018

BUY
$216.94 - $271.3 $7.2 Million - $9.01 Million
33,199 Added 64.19%
84,915 $20.3 Million
Q3 2017

Nov 14, 2017

BUY
$212.27 - $242.28 $11 Million - $12.5 Million
51,716
51,716 $11.5 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.39B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.